Andrea Tan

Stock Analyst at Goldman Sachs

(2.16)
# 1,305
Out of 4,452 analysts
33
Total ratings
37.93%
Success rate
-0.47%
Average return
Main Sectors:
Top Industries:

14 Stocks

Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $25.84
Upside: +19.97%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3$2
Current: $3.01
Upside: -33.55%
Insmed
May 29, 2024
Maintains: Buy
Price Target: $49$74
Current: $63.92
Upside: +15.77%
Sagimet Biosciences
May 16, 2024
Maintains: Buy
Price Target: $27$23
Current: $4.14
Upside: +455.56%
Iovance Biotherapeutics
Feb 29, 2024
Maintains: Buy
Price Target: $19$21
Current: $8.16
Upside: +157.35%
Tarsus Pharmaceuticals
Feb 29, 2024
Maintains: Neutral
Price Target: $19$30
Current: $30.98
Upside: -3.16%
Day One Biopharmaceuticals
Feb 27, 2024
Maintains: Buy
Price Target: $50$44
Current: $12.61
Upside: +248.93%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $2.81
Upside: -28.83%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $177.78
Upside: -10.00%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27$24
Current: $3.23
Upside: +643.03%
Fate Therapeutics
Jan 9, 2023
Maintains: Sell
Price Target: $10$4
Current: $3.61
Upside: +10.80%
Madrigal Pharmaceuticals
Dec 20, 2022
Maintains: Buy
Price Target: $178$375
Current: $277.59
Upside: +35.09%
Verve Therapeutics
Dec 15, 2022
Initiates: Sell
Price Target: $13
Current: $5.42
Upside: +139.85%
Vor Biopharma
May 24, 2022
Maintains: Neutral
Price Target: $6$4
Current: $1.15
Upside: +247.83%